INS and fatty liver disease: miRNA-412 targets PLIN2, which plays an important role in the development of hepatic steatosis and inflammatory processes, while miRNA-216A modulates the expression of PTEN, a core regulator of insulin signaling, insulin resistance development, and apoptosis.